Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Body mass index influence interferon-beta treatment response in multiple sclerosis.
Kvistad SS, Myhr KM, Holmøy T, Šaltytė Benth J, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Michelsen AE, Aukrust P, Ueland T, Sagen JV, Torkildsen Ø. Kvistad SS, et al. J Neuroimmunol. 2015 Nov 15;288:92-7. doi: 10.1016/j.jneuroim.2015.09.008. Epub 2015 Sep 26. J Neuroimmunol. 2015. PMID: 26531700 Clinical Trial.
Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.
Kvistad S, Myhr KM, Holmøy T, Bakke S, Beiske AG, Bjerve KS, Hovdal H, Løken-Amsrud KI, Lilleås F, Midgard R, Njølstad G, Pedersen T, Benth JŠ, Wergeland S, Torkildsen O. Kvistad S, et al. Mult Scler. 2014 Dec;20(14):1833-40. doi: 10.1177/1352458514533843. Epub 2014 May 19. Mult Scler. 2014. PMID: 24842958
No association of tobacco use and disease activity in multiple sclerosis.
Kvistad S, Myhr KM, Holmøy T, Benth JŠ, Løken-Amsrud KI, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Torkildsen Ø. Kvistad S, et al. Neurol Neuroimmunol Neuroinflamm. 2016 Jul 14;3(4):e260. doi: 10.1212/NXI.0000000000000260. eCollection 2016 Aug. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27458599 Free PMC article.
Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis.
Wesnes K, Myhr KM, Riise T, Kvistad SS, Torkildsen Ø, Wergeland S, Holmøy T, Midgard R, Bru A, Edland A, Eikeland R, Gosal S, Harbo HF, Kleveland G, Sørenes YS, Øksendal N, Bjørnevik K. Wesnes K, et al. Among authors: kvistad ss. Mult Scler Relat Disord. 2021 May;50:102801. doi: 10.1016/j.msard.2021.102801. Epub 2021 Jan 28. Mult Scler Relat Disord. 2021. PMID: 33636616 Free article. Clinical Trial.
Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study.
Lie IA, Kaçar S, Wesnes K, Brouwer I, Kvistad SS, Wergeland S, Holmøy T, Midgard R, Bru A, Edland A, Eikeland R, Gosal S, Harbo HF, Kleveland G, Sørenes YS, Øksendal N, Varhaug KN, Vedeler CA, Barkhof F, Teunissen CE, Bø L, Torkildsen Ø, Myhr KM, Vrenken H. Lie IA, et al. Among authors: kvistad ss. J Neurol Neurosurg Psychiatry. 2022 Jun 1;93(8):849-57. doi: 10.1136/jnnp-2021-328568. Online ahead of print. J Neurol Neurosurg Psychiatry. 2022. PMID: 35649699 Free PMC article.
The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis.
Lie IA, Wesnes K, Kvistad SS, Brouwer I, Wergeland S, Holmøy T, Midgard R, Bru A, Edland A, Eikeland R, Gosal S, Harbo HF, Kleveland G, Sørenes YS, Øksendal N, Barkhof F, Vrenken H, Myhr KM, Bø L, Torkildsen Ø. Lie IA, et al. Among authors: kvistad ss. Neurol Neuroimmunol Neuroinflamm. 2022 Jun 23;9(5):e200008. doi: 10.1212/NXI.0000000000200008. Print 2022 Sep. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35738901 Free PMC article.